These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1725053)

  • 1. Antiarrhythmic therapy and survival following myocardial infarction.
    Cowan JC; Coulshed DS; Zaman AG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S92-8. PubMed ID: 1725053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiarrhythmic agents: current situation].
    Bonhorst D
    Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
    Kellen JC; Ettinger A; Todd L; Brezsnyak ML; Campion J; McBride R; Thomas S; Corum J; Schron E
    Am J Crit Care; 1996 Jan; 5(1):19-25. PubMed ID: 8680488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).
    Avanzini F; Latini R; Maggioni A; Colombo F; Santoro E; Franzosi MG; Tognoni G
    Arch Intern Med; 1995 May; 155(10):1041-5. PubMed ID: 7748046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intermediary and substitution criteria in the development of anti-arrhythmia agents].
    Lièvre M; Leizorovicz A; Boissel JP
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():27-33. PubMed ID: 1669237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].
    Le Heuzey JY; Copie X; Iliou MC; Guize L
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():39-42. PubMed ID: 9749275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What remains of anti-arrhythmia drugs?].
    Lévy S
    Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1501-5. PubMed ID: 8010849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Class I anti-arrhythmia agents and prevention of sudden death following myocardial infarction].
    Boissel JP; Lièvre M; Rosenberg Y
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():49-54. PubMed ID: 1669239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective controlled randomized trial of prophylactic antiarrhythmic therapy in postmyocardial infarction patients with asymptomatic ventricular arrhythmias--study design and initial results.
    Pfisterer M; Burkart F; Follath F; Burckhardt D
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II41-5. PubMed ID: 3078156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to management of arrhythmias after myocardial infarction.
    Curtis AB; Mansour M
    Cardiovasc Clin; 1989; 20(1):259-81. PubMed ID: 2653637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmia agents following a myocardial infarct: the results of the CAST study. Cardiac Arrhythmia Suppression Trial].
    Hohnloser S
    Dtsch Med Wochenschr; 1991 Jul; 116(30):1166-7. PubMed ID: 1855450
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment after acute myocardial infarction: antiarrhythmic therapy and prophylaxis. Which drug for which patient?
    Bracchetti D; Naccarella F; Palmieri M; Fulvi M; Pavesi PC
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S79-83. PubMed ID: 2483239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation].
    Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():87-96. PubMed ID: 7846950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Philosophy of antiarrhythmic approaches to ventricular tachyarrhythmias close to the 21st century.
    Breithardt G; Haverkamp W; Böcker D; Borggrefe M
    Rev Port Cardiol; 1998 Dec; 17(12):981-91. PubMed ID: 9973859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk stratification following myocardial infarct].
    Buser PT; Osswald S; Rickenbacher P; Pfisterer M
    Schweiz Med Wochenschr; 1996 Jun; 126(23):1011-22. PubMed ID: 8701239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.